What are the drug interactions and safety considerations when using sertraline (Zoloft), aripiprazole (Abilify), and hydroxyzine together?

Drug Interactions Between Sertraline (Zoloft), Aripiprazole (Abilify), and Hydroxyzine

This combination can generally be used together with appropriate monitoring, though it carries specific risks that require clinical vigilance, particularly for QT prolongation, serotonin syndrome, and additive sedation. 1, 2

Key Interaction Concerns

QT Prolongation Risk

• Hydroxyzine is a known QT-prolonging medication that can increase the risk of cardiac arrhythmias including torsades de pointes 1
• Sertraline may interact with drugs that prolong the QT interval, though it has less propensity for this compared to other SSRIs like citalopram 1
• The combination of hydroxyzine with sertraline requires cardiac monitoring, particularly in patients with other risk factors for QT prolongation 1
• Consider obtaining a baseline ECG and monitoring for QTc prolongation, especially if other QT-prolonging medications are present 1

Serotonin Syndrome Risk

• Combining sertraline with aripiprazole requires caution for serotonin syndrome, though the risk is lower than with MAOIs or multiple serotonergic agents 1, 2
• Monitor for symptoms within 24-48 hours after starting or dose adjustments: mental status changes (confusion, agitation), neuromuscular hyperactivity (tremors, clonus, hyperreflexia), and autonomic hyperactivity (hypertension, tachycardia, diaphoresis) 1
• Start with low doses and increase slowly when combining serotonergic medications 1

Sedation and CNS Depression

• Hydroxyzine has significant anticholinergic and sedating properties that can impair cognition, cause delirium, and increase fall risk 1
• The combination of aripiprazole with benzodiazepines or antihistamines like hydroxyzine increases sedation intensity 3
• Monitor closely for excessive sedation, cognitive impairment, and orthostatic hypotension 1, 3

Pharmacokinetic Considerations

CYP450 Interactions

• Sertraline may interact with drugs metabolized by CYP2D6, though it has less effect on CYP450 isoenzymes compared to other SSRIs like fluvoxamine 1
• Aripiprazole metabolism can be affected by CYP3A4 and CYP2D6 inhibitors or inducers, but sertraline is not a strong inhibitor of these pathways 3
• No significant dose adjustment of aripiprazole is typically needed when combined with sertraline 3

Clinical Evidence for This Combination

Efficacy Data

• Aripiprazole augmentation of sertraline has demonstrated efficacy in treatment-resistant depression, with one randomized controlled trial showing significantly greater improvement in MADRS scores (-9.2 vs -7.2, p=0.0070) compared to sertraline alone 4
• The combination was well-tolerated with low discontinuation rates (1.9%) and mostly mild-to-moderate adverse events 4
• Akathisia occurred in 12.9% of patients receiving aripiprazole/sertraline combination versus 3.4% with sertraline alone 4

Safety Considerations

• One case report documented persistent hiccups in an adolescent treated with aripiprazole and sertraline, which resolved after discontinuing aripiprazole 5
• A rare case of myxedema coma was reported with this combination, though causality was uncertain 6
• The combination appears generally safe when appropriately monitored 4, 7

Monitoring Recommendations

Implement the following monitoring protocol:

• Baseline assessment: ECG (especially if hydroxyzine is included), vital signs, mental status 1
• Early monitoring (first 24-48 hours and after dose changes): Watch for serotonin syndrome symptoms, sedation level, orthostatic blood pressure 1, 3
• Ongoing monitoring: Movement disorders (akathisia, dystonia), cardiac rhythm if indicated, cognitive function 4
• Patient education: Instruct patients to report confusion, agitation, tremors, palpitations, or excessive sedation immediately 2

Clinical Pitfalls to Avoid

• Do not use this combination with MAOIs - contraindicated due to severe serotonin syndrome risk 1
• Avoid in patients with long QT syndrome when hydroxyzine is included 1
• Exercise particular caution in elderly patients who are more susceptible to anticholinergic effects, sedation, falls, and cardiac complications 1
• Be aware that hydroxyzine's anticholinergic properties may worsen conditions in patients with anticholinergic delirium or intoxication 1